We have developed a single-step synthesis of pyrazolopyridines and hydropyrazolopyridines by condensation 3-carbonitrile-5-aminopyrazole (1) with seven substituted α,β-unsaturated aldehydes in acid medium. Straightforward access to various pyrazolopyridines and hydropyrazolopyridines was achieved through disproportionation of initially formed pyrazolo Hantzsch dihydropyridines. All the pyrazolopyridines and hydropyrazolopyridines were well characterized by spectroscopic analyses.
Introduction
Pyrazolopyridines and its hydroderivatives are very interesting pyrazole derivatives with wideranging biological activities.
1 A number of pyrazolo [3,4-b] pyridines exhibit a wide range of biological activities, including interesting anxiolytic activity (e.g. tracazolate), dopamine D3 receptor antagonist, antiherpetic and antiallergic properties. 2 Usually, pyrazolopyridines can be synthesized via (i) 1,3-dipolar cycloaddition reaction from azomethine imines and alkynes; (ii) cyclocondensations of aminoazoles and aminoazines with α,β-unsaturated aldehydes and ketones containing at least two active hydrogen atoms. 3 While considerable progress has been made in synthesis of pyrazolo [3,4-b] pyridines, its hydroderivatives 4 such as 4,5,6,7-tetrahydropyrazolopyridines and 4,7-dihydropyrazolopyridines has received much less attention comparatively. The rapid assembly of molecular diversity is a significant goal of synthetic organic chemistry and one of the key paradigms of modern drug discovery. Great interest has been accumulated in recent years in the chemistry of Hantzsch 1,4-dihydropyridines upon many striking discoveries of bioactive roles 5 as potent blockers of calcium (Ca 2+ ) currents, and application in synthetic and physical organic chemistry as attractive biomimetic reducing agents. 6 Recently some reports about The mechanism for the formation of pyrazolo [3,4-b] pyridines and tetrahydropyrazolo [3,4-b] pyridines is depicted in Scheme 2. In the initial step, the Michael adduct was formed, which could undergo dehydration reaction to intermediate B. There are probably two pathways for intermediate B, such as aromatization in the oxygen by loosing water to obtain the corresponding products (19-24) (Skraup reaction 14 ) and further tautomerism to form pyrazolo Hantzsch dihydropyridines A. The calculated energy of this unstable Hantzsch analog A is 37.20 kcal/mol, which is unstable than the intermediate B (27.66 kcal/mol). And also, disproportionation of initially formed pyrazolo Hantzsch dihydropyridines A can provide the corresponding products (14-18, 19-24). The mainly products (19-24) was ascribed to the two potential different reactive routes above. For 7, further molecular condensation between B with excess 7, rearrangement and then dehydration to obtain the investigated 25. The final 4,7-dihydro-pyrazolopyridine (25 15 ) is more stable compared to 4,5,6,7-tetrahydro-pyrazolopyridine in cinnamaldehyde case due to the formation of conjugated π-electron systems.
Further exploring the reaction of 1 with (E)-2-methylpent-2-enal (26), it was found that the product 27 was obtained in high yield (70%). The corresponding hydropyrazolopyridine was not found, which indicate that the pyrazol Hantzsch dihydropyridine may be not formed. This can be 
Conclusions
In conclusion, we have demonstrated one-step reaction of 3-carbonitrile-5-aminopyrazole (1) with substituted α,β-unsaturated aldehyde (2-7, 26), which results in the formation of substituted pyrazolopyridines and tetrahydropyrazolopyridines through disproportionation of initially formed pyrazolo Hantzsch dihydropyridines. Further investigations on unstable Hantzsch analog for rapid assembly of molecular diversity may expand more exquisite heterocyclic compounds possessing potential bioactivities for modern drug discovery.
Experimental Section
General Procedures. Experiments were performed under a dry nitrogen atmosphere. Melting points were taken on a micro melting point apparatus made in Beijing and were uncorrected. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a Bruker AVANCE 400 MHz spectrometer using CDCl 3 as solvent at 298 K and TMS as an internal standard. IR spectra were recorded on a Nicolet Magna-IR 550 instrument using KBr pellets. High Resolution Mass spectra were obtained on MicroMass GCT CA 055 spectrometers. Analytical thin-layer chromatography (TLC) was carried out on precoated plated (silica gel 60 F254 ), and spots were visualized with ultraviolet light. All chemicals or reagents were purchased from standard commercial suppliers.
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